{
  "id": "nclex_ngn_trend_001",
  "caseId": "standalone_trend_safety_001",
  "itemType": "trend",
  "question": "The nurse is caring for a client admitted for atrial fibrillation with rapid ventricular response (RVR). The nurse reviews the client's electronic health record (EHR) at 0830. Based on the available data, which two (2) actions should the nurse take at this time?",
  "tabs": [
    {
      "id": "nursesNotes",
      "label": "Nurses' Notes",
      "content": [
        {
          "timestamp": "Day 1, 1800",
          "note": "Admitted from emergency department for new onset atrial fibrillation with RVR. Client reports palpitations and shortness of breath. History of Heart Failure (EF 35%) and Stage 3 Chronic Kidney Disease. Client lives alone and reports 'sometimes forgetting' medications due to cost. IV diltiazem drip initiated and titrated per protocol. Digoxin 0.25 mg IV administered as loading dose. Alert and oriented x4."
        },
        {
          "timestamp": "Day 2, 0815",
          "note": "Client reports feeling nauseated and 'more tired than yesterday.' States, 'The lights seem to have a weird yellow halo around them this morning.' Denies chest pain but feels 'a little dizzy when sitting up.' Bowel sounds are present in all four quadrants."
        }
      ]
    },
    {
      "id": "vitalSigns",
      "label": "Vital Signs",
      "isTrend": true,
      "vitals": [
        {
          "timestamp": "Day 1, 2000",
          "data": {
            "Heart Rate": "122",
            "Blood Pressure": "118/74",
            "Respiratory Rate": "20",
            "SpO2": "95% on room air",
            "Temperature": "37.1°C (98.8°F)"
          }
        },
        {
          "timestamp": "Day 2, 0400",
          "data": {
            "Heart Rate": "88",
            "Blood Pressure": "106/68",
            "Respiratory Rate": "18",
            "SpO2": "96% on room air",
            "Temperature": "37.0°C (98.6°F)"
          }
        },
        {
          "timestamp": "Day 2, 0800",
          "data": {
            "Heart Rate": "52",
            "Blood Pressure": "92/58",
            "Respiratory Rate": "16",
            "SpO2": "94% on room air",
            "Temperature": "36.9°C (98.4°F)"
          }
        }
      ]
    },
    {
      "id": "labResults",
      "label": "Laboratory Results",
      "labs": [
        {
          "timestamp": "Day 1, 1800 (Admission)",
          "results": {
            "Potassium": "3.6 mEq/L",
            "Magnesium": "1.8 mg/dL",
            "BUN": "28 mg/dL",
            "Creatinine": "1.5 mg/dL",
            "Troponin I": "<0.01 ng/mL"
          }
        },
        {
          "timestamp": "Day 2, 0600 (Morning Draw)",
          "results": {
            "Potassium": "3.2 mEq/L",
            "Magnesium": "1.6 mg/dL",
            "BUN": "42 mg/dL",
            "Creatinine": "2.2 mg/dL",
            "Troponin I": "<0.01 ng/mL"
          }
        }
      ]
    },
    {
      "id": "diagnostics",
      "label": "Diagnostics",
      "reports": [
        {
          "type": "12-Lead ECG Interpretation",
          "timestamp": "Day 2, 0810",
          "findings": "Atrial fibrillation with a controlled ventricular response at 50-55 bpm. ST segment depression ('scooping') noted in leads V4-V6. Frequent premature ventricular contractions (PVCs) present."
        }
      ]
    },
    {
      "id": "mar",
      "label": "MAR",
      "medications": [
        {
          "name": "Diltiazem",
          "dose": "5 mg/hr",
          "route": "IV Continuous Infusion",
          "frequency": "Continuous",
          "notes": "Titrate to keep HR < 100 bpm"
        },
        {
          "name": "Digoxin",
          "dose": "0.125 mg",
          "route": "PO",
          "frequency": "Daily",
          "notes": "Scheduled for 0900. Hold for HR < 60 bpm."
        },
        {
          "name": "Furosemide",
          "dose": "40 mg",
          "route": "IV",
          "frequency": "Daily",
          "notes": "Scheduled for 0900."
        },
        {
          "name": "Potassium Chloride",
          "dose": "20 mEq",
          "route": "PO",
          "frequency": "PRN",
          "notes": "For Potassium < 3.5 mEq/L"
        }
      ]
    }
  ],
  "options": [
    {
      "id": "opt_01",
      "label": "A",
      "content": "Withhold the 0900 dose of digoxin."
    },
    {
      "id": "opt_02",
      "label": "B",
      "content": "Administer the scheduled 0900 furosemide."
    },
    {
      "id": "opt_03",
      "label": "C",
      "content": "Notify the primary healthcare provider of the findings."
    },
    {
      "id": "opt_04",
      "label": "D",
      "content": "Administer the PRN potassium chloride."
    },
    {
      "id": "opt_05",
      "label": "E",
      "content": "Decrease the diltiazem infusion rate."
    },
    {
      "id": "opt_06",
      "label": "F",
      "content": "Request a breakfast tray for the client's nausea."
    }
  ],
  "correctAnswer": [
    "opt_01",
    "opt_03"
  ],
  "rationale": {
    "correct": "The nurse must analyze the trend data to recognize a life-threatening clinical situation: digoxin toxicity. The constellation of findings includes: significant bradycardia (HR 52), hypotension (BP 92/58), new neurological symptoms (fatigue, dizziness, xanthopsia - 'yellow halos'), and gastrointestinal upset (nausea). These are classic signs of toxicity. The laboratory data confirm risk factors that potentiate toxicity: worsening acute kidney injury (Creatinine rising from 1.5 to 2.2), which impairs digoxin clearance, and hypokalemia (K+ 3.2), which increases myocardial sensitivity to digoxin. The ECG findings (scooped STs, PVCs) further support this diagnosis. Digoxin inhibits the sodium-potassium ATPase pump in myocardial cells. This leads to an increase in intracellular sodium, which then drives an influx of calcium via the sodium-calcium exchanger. The increased intracellular calcium enhances myocardial contractility (positive inotropy) but also increases the risk of arrhythmias, especially in the presence of hypokalemia, which further reduces the pump's activity. Renal impairment reduces digoxin excretion, leading to accumulation and toxicity. Xanthopsia (yellow halos) is caused by digoxin's effect on the retina. Therefore, the absolute first priority is to prevent further harm by withholding the next dose of digoxin. The second priority is to immediately communicate these critical findings to the provider for further orders, which may include a STAT digoxin level and antidote (Digibind).",
    "incorrect": "The incorrect options either cause further harm, are not the highest priority, or fail to address the root cause of the client's deterioration.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Withhold the 0900 dose of digoxin.",
        "isCorrect": true,
        "justification": "This is a critical safety action. The client is exhibiting multiple signs and symptoms of digoxin toxicity. Administering another dose could lead to life-threatening dysrhythmias, such as complete heart block or ventricular tachycardia, and cardiovascular collapse. Digoxin toxicity can cause severe bradycardia by increasing vagal tone and slowing conduction through the AV node. This action directly prevents iatrogenic harm.",
        "scoreImpact": "positive"
      },
      {
        "label": "B",
        "content": "Administer the scheduled 0900 furosemide.",
        "isCorrect": false,
        "justification": "This is an unsafe action. Furosemide is a potassium-wasting diuretic. Administering it would worsen the client's existing hypokalemia (K+ 3.2), which would further potentiate the digoxin toxicity and increase the risk of fatal arrhythmias. Hypokalemia enhances digoxin's binding to the Na+/K+ ATPase pump, increasing its inhibitory effect and leading to increased intracellular calcium and subsequent arrhythmias. It would also likely worsen the hypotension.",
        "scoreImpact": "negative"
      },
      {
        "label": "C",
        "content": "Notify the primary healthcare provider of the findings.",
        "isCorrect": true,
        "justification": "This is a critical safety action. The nurse has identified a life-threatening condition that requires immediate medical intervention. The provider needs to be alerted to assess the client, order a serum digoxin level, consider administering an antidote, and adjust the plan of care. This is a core function of professional nursing.",
        "scoreImpact": "positive"
      },
      {
        "label": "D",
        "content": "Administer the PRN potassium chloride.",
        "isCorrect": false,
        "justification": "While correcting the hypokalemia is important, it is not the highest priority. The nurse should first withhold the offending agent (digoxin) and notify the provider. The provider may want to give IV potassium for faster correction or may have other orders. Acting unilaterally without escalation is inappropriate given the severity of the clinical picture. Rapid potassium administration can also cause cardiac arrhythmias.",
        "scoreImpact": "negative"
      },
      {
        "label": "E",
        "content": "Decrease the diltiazem infusion rate.",
        "isCorrect": false,
        "justification": "Although diltiazem (a calcium channel blocker) also contributes to bradycardia by blocking calcium channels in the SA and AV nodes, slowing heart rate and AV conduction, the overwhelming evidence (visual changes, nausea, hypokalemia, renal failure, ECG findings) points to digoxin as the primary culprit. While the diltiazem may need adjustment, the most critical issue is the digoxin toxicity. The provider should be notified to direct changes to infusions.",
        "scoreImpact": "negative"
      },
      {
        "label": "F",
        "content": "Request a breakfast tray for the client's nausea.",
        "isCorrect": false,
        "justification": "This action demonstrates a failure to recognize the cause of the client's symptoms. The nausea is a systemic sign of digoxin toxicity, not hunger. Digoxin can stimulate the chemoreceptor trigger zone (CTZ) in the brainstem, leading to nausea and vomiting. This action trivializes a life-threatening symptom and delays essential, life-saving interventions.",
        "scoreImpact": "negative"
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "nclexSubcategory": "Medication Administration and Error Prevention",
    "difficulty": "Level 5 - Highly Discriminating",
    "topicTags": [
      "Digoxin Toxicity",
      "Medication Safety",
      "Atrial Fibrillation",
      "Trend Analysis",
      "Acute Kidney Injury",
      "Electrolyte Imbalance",
      "Pharmacology"
    ]
  },
  "sbar": {
    "situation": "Client admitted for atrial fibrillation with RVR is now exhibiting signs of potential digoxin toxicity at 0830.",
    "background": "Client has a history of heart failure (EF 35%) and stage 3 chronic kidney disease. Admitted at 1800 yesterday with palpitations and shortness of breath. Receiving IV diltiazem and PO digoxin 0.125mg daily.",
    "assessment": "Client reports nausea, fatigue, dizziness, and visual disturbances (yellow halos) at 0815. Vital signs at 0800 show bradycardia (HR 52) and hypotension (BP 92/58). Labs from 0600 show hypokalemia (K+ 3.2) and worsening kidney function (Creatinine 2.2). ECG at 0810 shows atrial fibrillation with controlled ventricular response, ST depression, and PVCs.",
    "recommendation": "Withhold the scheduled 0900 digoxin dose and immediately notify the primary healthcare provider of these findings. Request an order for a STAT digoxin level and further instructions."
  },
  "clinicalPearls": [
    "Digoxin toxicity can be life-threatening and is potentiated by hypokalemia and renal insufficiency.",
    "Classic signs of digoxin toxicity include bradycardia, visual disturbances (xanthopsia), nausea, and dizziness.",
    "Trend analysis of vital signs, lab results, and patient reports is crucial for early detection of adverse drug effects.",
    "Always consider the patient's underlying conditions (e.g., kidney disease) when administering medications and monitoring for toxicity.",
    "Scooped ST segment depression on ECG is a characteristic finding in digoxin toxicity.",
    "Magnesium levels should also be monitored, as hypomagnesemia can also potentiate digoxin toxicity."
  ],
  "sentinelStatus": "healed_v2026_v8"
}